Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2012| Title: | Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look? |
| Epworth Authors: | Harrop, Sean Prince, Miles |
| Other Authors: | van der Weyden, Carrie |
| Keywords: | Peripheral T-cell Lymphoma PTCL Treatment Treatment Refactoriness Pralatrexate Efficacy Cancer Services Clinical Institute, Epworth HealthCare, Victoria, Australia |
| Issue Date: | Sep-2020 |
| Publisher: | Taylor & Francis |
| Citation: | Leuk Lymphoma . 2020 Sep;61(9):2031-2033 |
| Abstract: | Commentary regarding the treatment of angioimmunoblastic T-cell lymphoma with pralatrexate following failure of first line therapy. |
| URI: | http://hdl.handle.net/11434/2012 |
| DOI: | 10.1080/10428194.2020.1795164 |
| PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/32729765/ |
| ISSN: | 1029-2403 |
| Journal Title: | Leukemia & Lymphoma |
| Type: | Journal Article |
| Affiliated Organisations: | Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. Monash University, Melbourne, Australia. |
| Appears in Collections: | Cancer Services |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.